MDxHealth SA (NASDAQ:MDXH) stock skyrocketed on Friday after the diagnostic company reported mixed quarterly earnings.
The company reported a second-quarter loss of 18 cents, missing the consensus loss of 16 cents.
MDxHealth Reports Mixed Test Volume Results Sales rose 16% year over year to $27.20 million, beating the consensus of $25.884 million.
Tissue-based (Confirm mdx and GPS mdx) test volume was 12,525, a decrease of 1% over the prior-year period, but a 13% sequential increase.
Liquid-based (Exo mdx) test volume of 13,578 compared to Select mdx volume of 4,455 for the same period last year.
